News
ETON
35.70
+2.53%
0.88
Analysts’ Top Healthcare Picks: Eton Pharmaceuticals (ETON), Arrowhead Pharmaceuticals (ARWR)
TipRanks · 1d ago
Weekly Report: what happened at ETON last week (0615-0619)?
Weekly Report · 5d ago
Insider Shake-Up: Major Eton Pharmaceuticals Stock Sale Turns Heads on Wall Street
TipRanks · 06/18 02:03
Eton Pharma director Jennifer McKie Adams disposes of 50,000 common shares for $1.62 million
PUBT · 06/17 21:08
Weekly Report: what happened at ETON last week (0608-0612)?
Weekly Report · 06/15 09:05
Eton Shareholders Back Board Nominees and Auditor Selection
TipRanks · 06/09 21:47
Eton Pharmaceuticals shareholders elect two directors at annual meeting
PUBT · 06/09 20:32
Weekly Report: what happened at ETON last week (0601-0605)?
Weekly Report · 06/08 09:05
Eton Pharma CFO Judith Matthews files initial beneficial ownership statement
PUBT · 06/01 20:27
Weekly Report: what happened at ETON last week (0525-0529)?
Weekly Report · 06/01 09:05
Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right
Seeking Alpha · 05/31 03:31
Top Eton Pharma Insider Makes Major Move With Eye-Catching Stock Sale
TipRanks · 05/30 02:08
Eton Pharma CEO Sean Brynjelsen sells common shares worth $3.87 million
PUBT · 05/29 20:18
Top Eton Pharma Executive Makes Major Stock Move
TipRanks · 05/28 02:09
Eton Pharma Chief Business Officer David Krempa disposes of 99,999 common shares worth USD 3.24 million
PUBT · 05/27 22:29
Weekly Report: what happened at ETON last week (0518-0522)?
Weekly Report · 05/25 09:06
Analysts Are Bullish on These Healthcare Stocks: Personalis (PSNL), Eton Pharmaceuticals (ETON)
TipRanks · 05/21 16:50
Eton Pharmaceuticals: Buy Rating Reiterated as Strategic IMPAVIDO Deal Supports Asset-Light Growth and Unchanged $57 Price Target
TipRanks · 05/21 10:15
Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO
NASDAQ · 05/20 07:26
Eton Pharmaceuticals Signals Strong Momentum in Earnings Call
TipRanks · 05/20 07:06
More
Webull provides a variety of real-time ETON stock news. You can receive the latest news about Eton Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About ETON
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.